SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-22-008072
Filing Date
2022-03-01
Accepted
2022-03-01 16:41:29
Documents
16
Period of Report
2022-03-01
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K xene-8k_20220301.htm   iXBRL 8-K 43167
2 EX-1.1 xene-ex11_45.htm EX-1.1 43285
3 EX-5.1 xene-ex51_6.htm EX-5.1 10469
4 GRAPHIC g0inhwqtn2zd000001.jpg GRAPHIC 14552
5 GRAPHIC g0inhwqtn2zd000002.jpg GRAPHIC 28227
  Complete submission text file 0001564590-22-008072.txt   299523

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA xene-20220301.xsd EX-101.SCH 5709
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE xene-20220301_lab.xml EX-101.LAB 19390
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE xene-20220301_pre.xml EX-101.PRE 11583
10 EXTRACTED XBRL INSTANCE DOCUMENT xene-8k_20220301_htm.xml XML 3532
Mailing Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W
Business Address 200 - 3650 GILMORE WAY BURNABY A1 V5G 48W (604) 484-3300
Xenon Pharmaceuticals Inc. (Filer) CIK: 0001582313 (see all company filings)

IRS No.: 980661854 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36687 | Film No.: 22698883
SIC: 2834 Pharmaceutical Preparations